Health care

Lisanne Gitsels and Elena Kulinskaya quantify the impact of statins on longevity

Howard Kearns introduces LE01: a measure of longevity risk that puts it in context with other risks and mitigating factors over time.

With obesity rates showing no signs of declining, Nay Wynn examines their effects on health, and how actuaries can factor this in when underwriting life insurance policies.

Rachael Docking explains how factors throughout life can compound to make later life challenging, and points to how such inequalities might be tackled

Petra Wildemann explores how to manage the risks of epidemics – from zoonotic diseases to human infections

Kateryna Katyukha Swiegers considers recent advances in human genome editing and what these could mean for insurers and wider society

Jackie Li and Leonie Tickle discuss recent research results on measuring basis risk and hedge effectiveness in longevity risk transfer for pension plans

Aisling Kennedy reports on the latest data on the incidence and risks of cancer and how this affects critical illness costs for insurers

Artificial organs look likely to play an increasingly important role in transplantation. Nay Wynn considers the implications for insurance

Mark Williams questions the sustainability of gender-based actuarial factors in pension schemes in light of social and actuarial rationale